August 28th, 2013
Platelet Reactivity Testing: Do You or Don’t You?
In the multicenter ADEPT DES study, investigators used theVerifyNow point-of-care assay (Accumetrics, San Diego, CA, USA) to assess platelet reactivity (by P2Y12 reaction units; PRU) in patients after successful PCI. The investigators found that high platelet reactivity in patients on clopidogrel was not an independent predictor of mortality, and that PRU did not provide utility beyond baseline risk profile in assessing the patients’ propensity for death.
Sorry, there are no polls available at the moment.
- Why or why not?
- If you do, how do you use that information?
- Will the ADEPT DES study affect your use of platelet reactivity testing?